[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-10", "acceptance_datetime": "2025-11-10T11:04:42Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001671858", "sic": "2834", "tickers": ["SPRY"], "company_name": "ARS Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-273111", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-273111/files/spry-20250930_htm.xml", "financials": {"income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -51151000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -51151000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "research_and_development": {"value": 2751000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 85693000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_average_shares": {"value": 98807600.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_after_tax": {"value": -51151000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "selling_general_and_administrative_expenses": {"value": 74751000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": 32501000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "costs_and_expenses": {"value": 85693000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_parent": {"value": -51151000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_average_shares": {"value": 98807600.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "other_operating_expenses": {"value": 8191000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -0.52, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "revenues": {"value": 32501000.0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -53192000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.52, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -51112000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -51112000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -51112000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"intangible_assets": {"value": 14729000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "liabilities": {"value": 225148000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "prepaid_expenses": {"value": 1278000.0, "unit": "USD", "label": "Prepaid Expenses", "order": 240}, "current_assets": {"value": 338863000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "long_term_debt": {"value": 96229000.0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "equity": {"value": 147655000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 50877000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 8382000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 18002000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 37047000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_current_assets": {"value": 316158000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "liabilities_and_equity": {"value": 372803000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 147655000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 33940000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 174271000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 1209000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_noncurrent_liabilities": {"value": 78042000.0, "unit": "USD", "label": "Other Non-current Liabilities", "order": 820}, "wages": {"value": 5448000.0, "unit": "USD", "label": "Wages", "order": 730}, "assets": {"value": 372803000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "inventory": {"value": 21427000.0, "unit": "USD", "label": "Inventory", "order": 230}}}}, {"start_date": "2025-04-01", "end_date": "2025-07-01", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001671858", "sic": "2834", "tickers": ["SPRY"], "company_name": "ARS Pharmaceuticals, Inc.", "financials": {"balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 192321000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": -192321000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 192321000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": -192321000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -45001000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -45001000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -45001000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-14", "acceptance_datetime": "2025-05-14T11:03:05Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001671858", "sic": "2834", "tickers": ["SPRY"], "company_name": "ARS Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-070900", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-070900/files/spry-20250331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_continuing": {"value": -10953000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -40742000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 725000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 29064000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -10953000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 725000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 29064000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -40742000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -34088000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -34088000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -34088000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "other_operating_expenses": {"value": 814000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -33940000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "depreciation_and_amortization": {"value": 280000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "diluted_average_shares": {"value": 98060636.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss": {"value": -33940000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 45150000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -33940000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -0.35, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": -37177000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": -0.35, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "selling_general_and_administrative_expenses": {"value": 41104000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "income_loss_from_continuing_operations_before_tax": {"value": 7973000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -33940000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 98060636.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 45150000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 7973000.0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 2952000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "balance_sheet": {"other_current_assets": {"value": 288249000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "accounts_payable": {"value": 4095000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 23458000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 228974000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 327318000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 327318000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 228974000.0, "unit": "USD", "label": "Equity", "order": 1400}, "inventory": {"value": 7270000.0, "unit": "USD", "label": "Inventory", "order": 230}, "current_liabilities": {"value": 27622000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 303860000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "prepaid_expenses": {"value": 8341000.0, "unit": "USD", "label": "Prepaid Expenses", "order": 240}, "liabilities": {"value": 98344000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 1075000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 23527000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "intangible_assets": {"value": 7241000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "other_noncurrent_assets": {"value": 15142000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0001671858", "sic": "2834", "tickers": ["SPRY"], "company_name": "ARS Pharmaceuticals, Inc.", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 351153000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 23440000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 1029000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": 256798000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 8458000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 9870000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_assets": {"value": 329083000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "noncurrent_assets": {"value": 16858000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 334295000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 256798000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 351153000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 70915000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 94355000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "intangible_assets": {"value": 7371000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "inventory": {"value": 5212000.0, "unit": "USD", "label": "Inventory", "order": 230}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 13570000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 49815000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": 49815000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": 49815000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": 42004000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -101760000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -101760000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 70916000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 11160000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 70916000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": 42004000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 11160000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "income_statement": {"benefits_costs_expenses": {"value": 80863000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 28015000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "research_and_development": {"value": 3027000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 86581000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_average_shares": {"value": 5608010.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": 47197000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": 49934000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "selling_general_and_administrative_expenses": {"value": 35492000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "basic_average_shares": {"value": 153843, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_before_tax": {"value": 5718000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": 0.51, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_expenses": {"value": 39384000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": 49934000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": 49934000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": 0.51, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": 49934000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 865000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "depreciation_and_amortization": {"value": 0, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-13", "acceptance_datetime": "2024-11-13T12:02:17Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001671858", "sic": "2834", "tickers": ["SPRY"], "company_name": "ARS Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-125924", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-125924/files/spry-20240930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -18644000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -18644000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -18644000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 8812000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 843000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "inventory": {"value": 715000, "unit": "USD", "label": "Inventory", "order": 230}, "liabilities": {"value": 16623000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 8276000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 469000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 208789000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 200978000.0, "unit": "USD", "label": "Equity", "order": 1400}, "intangible_assets": {"value": 7500000.0, "unit": "USD", "label": "Intangible Assets", "order": 330}, "current_liabilities": {"value": 16623000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_assets": {"value": 208074000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_current_liabilities": {"value": 8347000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 217601000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 200978000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 217601000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -21748000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "basic_earnings_per_share": {"value": -0.2, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "research_and_development": {"value": 4423000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_average_shares": {"value": 97032331.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": -19128000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 2068000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.2, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -19128000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "selling_general_and_administrative_expenses": {"value": 19281000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -19128000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 12000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_expenses": {"value": 23816000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 97032331.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_after_tax": {"value": -19128000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 23816000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "depreciation_and_amortization": {"value": 100000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "income_loss_from_continuing_operations_before_tax": {"value": 2068000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 680000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 3031000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 16818000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -14467000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 16818000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -14467000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 3031000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 680000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-06", "acceptance_datetime": "2024-08-06T20:05:50Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001671858", "sic": "2834", "tickers": ["SPRY"], "company_name": "ARS Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-091776", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-091776/files/spry-20240630_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -12537000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -12537000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -12537000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 545000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -7279000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -7279000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -19380000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 545000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -12646000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -19380000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -12646000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "balance_sheet": {"other_current_liabilities": {"value": 3453000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 592000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 220738000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 221966000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 1228000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 6725000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 215241000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 636000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 6725000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 221966000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 3272000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 215241000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "income_statement": {"basic_average_shares": {"value": 96827687.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -12516000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": 500000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "selling_general_and_administrative_expenses": {"value": 114000, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_average_shares": {"value": 96827687.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -12516000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 15840000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "research_and_development": {"value": 6896000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_parent": {"value": -12516000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_earnings_per_share": {"value": -0.13, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": -15340000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -12516000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 500000, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 15840000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_earnings_per_share": {"value": -0.13, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 8830000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-09", "acceptance_datetime": "2024-05-09T20:12:18Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001671858", "sic": "2834", "tickers": ["SPRY"], "company_name": "ARS Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-056967", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-056967/files/spry-20240331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -6710000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -6710000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 258000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 258000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -14965000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -8513000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -8513000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -14965000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -10292000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 13192000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_average_shares": {"value": 96486480.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 7865000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -10292000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -10292000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 13192000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "selling_general_and_administrative_expenses": {"value": 93000, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "diluted_earnings_per_share": {"value": -0.11, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "diluted_average_shares": {"value": 96486480.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_after_tax": {"value": -10292000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -13192000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 5234000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_earnings_per_share": {"value": -0.11, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": -10292000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -10465000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -10465000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -10465000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"liabilities_and_equity": {"value": 227583000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 2876000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "fixed_assets": {"value": 616000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 223868000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 223868000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 1342000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 226241000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 227583000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 726000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 3715000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 3715000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 839000, "unit": "USD", "label": "Accounts Payable", "order": 710}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001671858", "sic": "2834", "tickers": ["SPRY"], "company_name": "ARS Pharmaceuticals, Inc.", "financials": {"income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -7168000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -7168000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": -0.06999999999999995, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "depreciation_and_amortization": {"value": 0, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "net_income_loss": {"value": -7168000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -10226000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 10226000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "research_and_development": {"value": 3404000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "costs_and_expenses": {"value": 10226000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_average_shares": {"value": 305310, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 5882000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_earnings_per_share": {"value": -0.06999999999999995, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": 0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -7168000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_average_shares": {"value": 305310, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "balance_sheet": {"assets": {"value": 233188000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 231726000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 1632000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 1462000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 574000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 759000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 888000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 230760000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 2391000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 233188000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 230760000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 37000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 2428000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "cash_flow_statement": {"net_cash_flow": {"value": 10439000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 1805000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 1805000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 26039000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 26039000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -17405000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -17405000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 10439000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -6958000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -6958000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -6958000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-09", "acceptance_datetime": "2023-11-09T21:04:53Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001671858", "sic": "2834", "tickers": ["SPRY"], "company_name": "ARS Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-061996", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-061996/files/spry-20230930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -12763000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -46643000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -58485000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 921000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -46643000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 921000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -58485000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -12763000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "income_statement": {"benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_average_shares": {"value": 95576627.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_average_shares": {"value": 95576627.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -14866000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": -0.16, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "costs_and_expenses": {"value": 17978000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -14866000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -14866000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -17978000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 3002000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": -0.16, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 14876000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "depreciation_and_amortization": {"value": 100000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "operating_expenses": {"value": 17978000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -14866000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -14866000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 11272000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 2966000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 244466000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 8214000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 237284000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 4090000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 92000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 248556000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 3473000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities_and_equity": {"value": 248556000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 237284000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 11180000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 617000, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -14847000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -14847000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -14847000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-10", "acceptance_datetime": "2023-08-10T20:08:01Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001671858", "sic": "2834", "tickers": ["SPRY"], "company_name": "ARS Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-041310", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-041310/files/spry-20230630_htm.xml", "financials": {"income_statement": {"net_income_loss": {"value": -17370000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_average_shares": {"value": 94911268.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_expenses": {"value": 20613000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": -0.18, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "costs_and_expenses": {"value": 20613000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_average_shares": {"value": 94911268.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "research_and_development": {"value": 7308000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_earnings_per_share": {"value": -0.18, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": 10000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -17370000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 10000, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -17370000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -20603000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -17370000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 13305000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}, "balance_sheet": {"current_liabilities": {"value": 10054000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 594000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 8553000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 3718000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 255034000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 258752000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 248552000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 3124000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 248552000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 1501000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 258752000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 10200000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -17618000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -17618000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -17618000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 2854000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 31155000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 44970000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 44970000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 2854000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -16669000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -16669000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 31155000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-15", "acceptance_datetime": "2023-05-15T13:05:55Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001671858", "sic": "2834", "tickers": ["SPRY"], "company_name": "ARS Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-021997", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-021997/files/spry-20230331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -111546000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -12429000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -111546000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -122656000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -122656000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 1319000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -12429000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 1319000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "balance_sheet": {"other_noncurrent_assets": {"value": 3258000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities_and_equity": {"value": 271192000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 267350000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 584000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 261155000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 3842000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 10037000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 261155000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 9838000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 271192000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 2580000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 7258000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "income_statement": {"net_income_loss": {"value": -14961000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_average_shares": {"value": 94227313.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "other_operating_expenses": {"value": 12181000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -14961000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": 20000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 6552000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -14961000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -14961000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_earnings_per_share": {"value": -0.16, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "revenues": {"value": 20000, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 18733000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_average_shares": {"value": 94227313.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "costs_and_expenses": {"value": 18733000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_income_loss": {"value": -18713000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.16, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -15300000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -15300000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -15300000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}]